The ethical conduct of clinical research involving critically ill patients in the United States and Canada: Principles and recommendations

American Journal of Respiratory and Critical Care Medicine

Volumn 170, Issue 12, 2004, Pages 1375-1384

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

CANADA; CLINICAL RESEARCH; CLINICAL STUDY; CRITICAL ILLNESS; HEALTH EDUCATION; INFORMED CONSENT; INTENSIVE CARE; INTENSIVE CARE UNIT; METHODOLOGY; PRIORITY JOURNAL; RESEARCH ETHICS; REVIEW; UNITED STATES;

AMERICAN THORACIC SOCIETY; BIOMEDICAL AND BEHAVIORAL RESEARCH;

BIOMEDICAL RESEARCH; CANADA; CONFLICT OF INTEREST; CRITICAL CARE; CRITICAL ILLNESS; HUMANS; INFORMED CONSENT; RESEARCH DESIGN; UNITED STATES;

EID: 10644279911     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/rccm.200406-726ST     Document Type: Review

References (51)

1. Angus DC, Barnato AE, Linde-Zwrible WT, Weissfeld LA, Watson S, Rickert T, Rubenfeld G on behalf of the Robert Wood Johnson Foundation ICU End of life Peer Group. Use of intensive care at the end of life in the United States. Crit Care Med 2004;32:638-643.
2. Kersten A, Milbrandt EB, Rahim MT, Watson RS, Clermont G, Angus DC, Linde-Zwirble WT. How big is critical care in the US?[abstract]. Crit Care Med 2003;31:A8.
3. White J. Uses and abuses of long term Medicare cost estimates. Health Aff (Millwood) 1999;18:63-79.
4. Angus DC, Kelley MA, Schmitz RJ, White A, Popovich J Jr, for the Committee on Manpower for Pulmonary and Critical Care Societies (COMPACCS). Current and projected workforce requirements for care of the critically ill and patients with pulmonary disease: can we meet the requirements of an aging population? JAMA 2000;284:2762-2770.
5. Brochard L. Searching for evidence: don't forget the foundations. Intensive Care Med 2003;29:2109-2111.
6. Luce JM. Is the concept of informed consent applicable to clinical research involving critically ill subjects? Crit Care Med 2003;31:S153-S160.
7. Truog RD, Robinson W, Randolph A, Morris A. Is informed consent always necessary for randomized, controlled trials? N Engl J Med 1999;340:804-807.
8. National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. The Belmont Report: Ethical Principles and Guidelines for the Protection of Human Subjects in Research. Washington, DC: US Government Printing Office, 1979.
9. Emanuel EJ, Wendler D, Grady C. What makes clinical research ethical? JAMA 2000;283:2701-2711.
10. Nuremberg Code. In: Trials of War Criminals Before the Nuremberg Military Tribunals Under Control Council Law No. 10. Vol 2, Nuremberg, October 1946-April 1949. Washington, DC: US Government Printing Office, 1949.
11. World Medical Association. Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects, Revised. Ferney-Voltaire, France: World Medical Association, 2000.
12. Freedman B. Equipoise and the ethics of clinical research. N Engl J Med 1987;317:141-145.
13. Institute of Medicine. Responsible Research: a Systems Approach to Protecting Research Participants. Washington, DC: National Academies Press, 2003.
14. Agrawal M, Emanuel EJ. Ethics of phase 1 oncology studies; reexamining the arguments and data. JAMA 2003;290:1075-1082.
15. Appelbaum PS, Roth LH, Lidz CW, Benson P, Winslade W. False hopes and best data: consent to research and the therapeutic misconception. Hastings Cent Rep 1987;17:20-24.
16. Miller FG, Rosenstein DL. The therapeutic orientation to clinical trials. N Engl J Med 2003;348:1383-1386.
17. Grunberg SM, Cefalu WT. The integral role of clinical research in clinical care. N Engl J Med 2003;348:1386-1388.
18. Halpern SD, Karlawish JHT, Berlin JA. The continuing unethical conduct of underpowered clinical trials. JAMA 2002;288:358-362.
19. Steinbrook R. How best to ventilate? Trial design and patient safety in studies of the acute respiratory distress syndrome. N Engl J Med 2003;348:1393-1401.
20. Steinbrook R. Trial design and patient safety - the debate continues. N Engl J Med 2003;349:629-630.
21. Miller FG, Silverman HJ. The ethical relevance of the standard of care in the design of clinical trials. Am J Respir Crit Care Med 2004;169:562-564.
22. Silverman HJ, Miller FG. Control group selection in critical care randomized controlled trials evaluating interventional strategies: an ethical assessment. Crit Care Med 2004;32:852-857.
23. Krishnan JA, Moore D, Robeson C, Rand CS, Fessler HE. A prospective, controlled trial of s protocol-based strategy to discontinue mechanical ventilation. Am J Respir Crit Care Med 2004;169:673-678.
24. Sandham JD, Hull RD, Brant RF, Knox L, Pineo GF, Doig CJ, Laporta DP, Viner S, Passerini L, Devitt H, et al., for the Canadian Critical Care Trials Group. A randomised, controlled trial of the use of pulmonary-artery catheters in high-risk surgical patients. N Engl J Med 2003; 348:5-14.
25. Richard-PAC, Richard C, Warszawski J, Anguel N, Deye N, Combes A, Barnoud D, Boulain T, Lefort Y, Fartoukh M, et al., for the French Pulmonary Artery Catheter Study Group. Early use of the pulmonary artery catheter and outcomes in patients with shock and acute respiratory distress syndrome: a randomized controlled trial. JAMA 2003;290: 2713-2720.
26. Department of Health and Human Services. Common Rule (45 CFR 46). Federal policy for the protection of human subjects; notices and rules. 1991: 28003-28032.
27. Slutsky AS, Lavery JV. Data safety and monitoring boards. N Engl J Med 2004;350:1143-1147.
28. Ellenberg SS, Fleming TR, DeMets DL. Data monitoring committees in clinical trials: a practical perspective. Chichester, England: John Wiley; 2002.
29. Freeman BD, Danner RL, Banks SM, Natanson C. Safeguarding patients in clinical trials with high mortality rates. Am J Respir Crit Care Med 2001;164:190-192.
30. Steinbrook R. Protecting research subjects: the crisis at Johns Hopkins. N Engl J Med 2002;346:716-720.
31. Coppolino M, Ackerson L. Do surrogate decision makers provide accurate consent for intensive care research? Chest 2001;119:603-612.
32. Puchalski CM, Zhong Z, Jacobs MM, Fox E, Lynn J, Harrold J, Galanos A, Phillips RS, Califf R, Teno JM. Patients who want their family and physician to make resuscitation decisions for them: observations from SUPPORT and HELP. J Am Geriatr Soc 2000;48:S84-S90.
33. Silverman HJ, Luce JM, Schwartz J. Protecting subjects with decisional impairment in research: the need for a multifaceted approach. Am J Respir Crit Care Med 2004;169:10-14.
34. Partridge AH, Winer EP. Informing clinical trial participants about study results. JAMA 2002;288:363-365.
35. Karlawish JHT. Research involving cognitively impaired adults. N Engl J Med 2003;348:1389-1392.
36. Weijer C. The ethical analysis of risk. J Law Med Ethics 2000;28:344-361.
37. Drazen JM. Controlling research trials. N Engl J Med 2003;348:1377-1380,
38. Koski G. Ethics, science, and oversight of critical care research: the Office of Human Research Protections. Am J Respir Crit Care Med 2004;169:982-986.
39. Miller FG, Rosenstein DL, DeRenzo EG. Professional integrity in clinical research. JAMA 1998;280:1449-1454.
40. Wilhelmsen L. Role of the Data and Safety Monitoring Committee (DSMC). Stat Med 2002;21:2823-2829.
41. Christian MC, Goldberg JL, Killen J, Abrams JS, McCabe MS, Mauer JK, Wittes RE. A central institutional review board for multi-institutional trials. N Engl J Med 2002;346:1405-1408.
42. Korn D. Industry, academia, investigator: managing the relationships. Acad Med 2002;77:1089-1095.
43. Rennie D. Thyroid storm. JAMA 1997;277:1238-1243.
44. Chalmers I. Underreporting research is scientific misconduct. JAMA 1990;263:1405-1408.
45. DeAngelis CD, Drazen J, Frizelle FA, Haug C, Hoey J, Horton R, Kotzin S, Laine C, Marusic A, Overbeke AJPM, et al. Clinical Trial Registration: A Statement from the International Committee of Medical Journal Editors. JAMA 2004;292:1363-1364.
46. Begg C, Cho M, Eastwood S, Horton R, Moher D, Olkin I, Pitkin R, Rennie D, Schultz KF, Simel D, et al. Improving the quality of reporting of randomized controlled trials: the CONSORT statement. JAMA 1996;276:637-640.
47. Tobin MJ. Conflicts on interest and the AJRCCM: restating policy and a new form to upload. Am J Respir Crit Care Med 2003;167:1161-1166.
48. Davidoff F, DeAngelis CD, Drazen JM, Nicholls MG, Hoey J, Hojgaard L, Horton R, Kotzin S, Nicholls MG, Nylenne M. Sponsorship, authorship, and accountability. N Engl J Med 2001;345:825-826; discussion 826-827.
49. Als-Nielsen B, Chen W, Gluud C, Kjaergard LL. Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events? JAMA 2003;290:921-928.
50. Cook D, Guyatt G. Colloid use for fluid resuscitation: evidence and spin. Ann Intern Med 2001;135:205-208.
51. Choudhry NK, Stelfox HT, Detsky AS. Relationships between authors of clinical practice guidelines and the pharmaceutical industry. JAMA 2002;287:612-617.